By competitively inhibiting the adsorption of plasminogen on the fibrin network, the generation of plasmin is reduced, thereby preventing fibrin degradation and bleeding.

By competitively inhibiting the adsorption of plasminogen on the fibrin network, the activation of plasminogen is reduced, thereby inhibiting the formation of fibrin degradation products and the dissolution and bleeding of blood clots.

Tranexamic acid competitively inhibits the adsorption of plasminogen on the fibrin network, reduces the activation of plasminogen, and thus prevents the dissolution and bleeding of blood clots caused by fibrin degradation products.

It participates in amino acid metabolism, synthesis of neurotransmitters, synthesis of collagen and tissue cell interstitial, can reduce the permeability of capillaries, accelerate blood coagulation, stimulate coagulation function, promote iron absorption in the intestine, promote the decrease of blood lipids, increase resistance to infection, participate in detoxification function, and has antihistamine effect and prevents the formation of carcinogens (nitrosamines).

It promotes brain metabolism and improves brain circulation by reducing cerebrovascular resistance and increasing cerebral blood flow. It also enhances the function of the ascending activation system of the brainstem reticular structure, the function of the pyramidal system, improves motor paralysis, and has a certain effect on promoting the recovery of brain function and awakening.